Combination therapy with antibody and interleukin-2 gene transfer against multidrug-resistant cancer cells

Tsutomu Shinohara, Yoshikazu Sugimoto, Shigeo Sato, Saburo Sone, Takashi Tsuruo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In the present study, we examined the effect of interleukin-2 (IL-2) gene transfer into multidrug resistance (MDR) cancer cells on the therapeutic efficacy of MRK16. Human MDR ovarian cancer cells, AD10, were transduced with a bicistronic IL-2 retrovirus, Ha-IL2-IRES-Neo. The G418-resistant population, IL2-AD10, secreted IL-2 into the culture supernatant and did not form a tumor mass in nude mice. The IL2-AD10 cells were more susceptible to the cytotoxicity of murine spleen cells than AD10 cells in vitro. For examination of the effect of IL-2 gene transfer on the antitumor activity of MRK16 against P-glycoprotein-positive tumors, IL2-AD10 cells were co-transplanted s.c. with AD10 cells into nude mice in a ratio of 1:3, and the mice were treated with MRK16 on days 2 and 7. MRK16 markedly inhibited the growth of AD10 cells mixed with IL2-AD10 cells under conditions (0.3-1 μg/body) where it showed only marginal effects on the growth of AD10 tumors. These findings suggest that IL-2 gene transfer potentiates the antitumor activity of MRK16 against MDR tumors.

Original languageEnglish
Pages (from-to)1100-1107
Number of pages8
JournalJapanese Journal of Cancer Research
Volume88
Issue number11
Publication statusPublished - 1997 Nov
Externally publishedYes

Fingerprint

Interleukin-2
Antibodies
Genes
Neoplasms
Multiple Drug Resistance
Therapeutics
Nude Mice
Alzheimer Disease 10
P-Glycoprotein
Retroviridae
Growth
Ovarian Neoplasms
Spleen
Population

Keywords

  • Antibody-dependent cell-mediated cytotoxicity
  • Interleukin-2
  • Internal ribosome entry site
  • Multidrug resistance
  • Natural killer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Combination therapy with antibody and interleukin-2 gene transfer against multidrug-resistant cancer cells. / Shinohara, Tsutomu; Sugimoto, Yoshikazu; Sato, Shigeo; Sone, Saburo; Tsuruo, Takashi.

In: Japanese Journal of Cancer Research, Vol. 88, No. 11, 11.1997, p. 1100-1107.

Research output: Contribution to journalArticle

Shinohara, Tsutomu ; Sugimoto, Yoshikazu ; Sato, Shigeo ; Sone, Saburo ; Tsuruo, Takashi. / Combination therapy with antibody and interleukin-2 gene transfer against multidrug-resistant cancer cells. In: Japanese Journal of Cancer Research. 1997 ; Vol. 88, No. 11. pp. 1100-1107.
@article{61eff3b096574ed9a0f60953d8fe927b,
title = "Combination therapy with antibody and interleukin-2 gene transfer against multidrug-resistant cancer cells",
abstract = "In the present study, we examined the effect of interleukin-2 (IL-2) gene transfer into multidrug resistance (MDR) cancer cells on the therapeutic efficacy of MRK16. Human MDR ovarian cancer cells, AD10, were transduced with a bicistronic IL-2 retrovirus, Ha-IL2-IRES-Neo. The G418-resistant population, IL2-AD10, secreted IL-2 into the culture supernatant and did not form a tumor mass in nude mice. The IL2-AD10 cells were more susceptible to the cytotoxicity of murine spleen cells than AD10 cells in vitro. For examination of the effect of IL-2 gene transfer on the antitumor activity of MRK16 against P-glycoprotein-positive tumors, IL2-AD10 cells were co-transplanted s.c. with AD10 cells into nude mice in a ratio of 1:3, and the mice were treated with MRK16 on days 2 and 7. MRK16 markedly inhibited the growth of AD10 cells mixed with IL2-AD10 cells under conditions (0.3-1 μg/body) where it showed only marginal effects on the growth of AD10 tumors. These findings suggest that IL-2 gene transfer potentiates the antitumor activity of MRK16 against MDR tumors.",
keywords = "Antibody-dependent cell-mediated cytotoxicity, Interleukin-2, Internal ribosome entry site, Multidrug resistance, Natural killer",
author = "Tsutomu Shinohara and Yoshikazu Sugimoto and Shigeo Sato and Saburo Sone and Takashi Tsuruo",
year = "1997",
month = "11",
language = "English",
volume = "88",
pages = "1100--1107",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Combination therapy with antibody and interleukin-2 gene transfer against multidrug-resistant cancer cells

AU - Shinohara, Tsutomu

AU - Sugimoto, Yoshikazu

AU - Sato, Shigeo

AU - Sone, Saburo

AU - Tsuruo, Takashi

PY - 1997/11

Y1 - 1997/11

N2 - In the present study, we examined the effect of interleukin-2 (IL-2) gene transfer into multidrug resistance (MDR) cancer cells on the therapeutic efficacy of MRK16. Human MDR ovarian cancer cells, AD10, were transduced with a bicistronic IL-2 retrovirus, Ha-IL2-IRES-Neo. The G418-resistant population, IL2-AD10, secreted IL-2 into the culture supernatant and did not form a tumor mass in nude mice. The IL2-AD10 cells were more susceptible to the cytotoxicity of murine spleen cells than AD10 cells in vitro. For examination of the effect of IL-2 gene transfer on the antitumor activity of MRK16 against P-glycoprotein-positive tumors, IL2-AD10 cells were co-transplanted s.c. with AD10 cells into nude mice in a ratio of 1:3, and the mice were treated with MRK16 on days 2 and 7. MRK16 markedly inhibited the growth of AD10 cells mixed with IL2-AD10 cells under conditions (0.3-1 μg/body) where it showed only marginal effects on the growth of AD10 tumors. These findings suggest that IL-2 gene transfer potentiates the antitumor activity of MRK16 against MDR tumors.

AB - In the present study, we examined the effect of interleukin-2 (IL-2) gene transfer into multidrug resistance (MDR) cancer cells on the therapeutic efficacy of MRK16. Human MDR ovarian cancer cells, AD10, were transduced with a bicistronic IL-2 retrovirus, Ha-IL2-IRES-Neo. The G418-resistant population, IL2-AD10, secreted IL-2 into the culture supernatant and did not form a tumor mass in nude mice. The IL2-AD10 cells were more susceptible to the cytotoxicity of murine spleen cells than AD10 cells in vitro. For examination of the effect of IL-2 gene transfer on the antitumor activity of MRK16 against P-glycoprotein-positive tumors, IL2-AD10 cells were co-transplanted s.c. with AD10 cells into nude mice in a ratio of 1:3, and the mice were treated with MRK16 on days 2 and 7. MRK16 markedly inhibited the growth of AD10 cells mixed with IL2-AD10 cells under conditions (0.3-1 μg/body) where it showed only marginal effects on the growth of AD10 tumors. These findings suggest that IL-2 gene transfer potentiates the antitumor activity of MRK16 against MDR tumors.

KW - Antibody-dependent cell-mediated cytotoxicity

KW - Interleukin-2

KW - Internal ribosome entry site

KW - Multidrug resistance

KW - Natural killer

UR - http://www.scopus.com/inward/record.url?scp=0031449749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031449749&partnerID=8YFLogxK

M3 - Article

C2 - 9439686

AN - SCOPUS:0031449749

VL - 88

SP - 1100

EP - 1107

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 11

ER -